Antigen CA125 in tumor tissue and serum from patients with adenocarcinoma of the ovary.

[1]  M. Shelley,et al.  The clinical value of serum CA125 levels in ovarian cancer patients receiving platinum therapy. , 1987, European journal of cancer & clinical oncology.

[2]  M. Shelley,et al.  Evaluation of an Immunoradiometric Assay for the Detection of an Ovarian Tumour Marker, CA125, in Serum , 1986, Annals of clinical biochemistry.

[3]  C. Hudson,et al.  The value of the monoclonal antibody (cancer antigen 125) in serial monitoring of ovarian cancer: a comparison with circulating immune complexes , 1985, British journal of obstetrics and gynaecology.

[4]  R. Bast,et al.  Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinoma. , 1985, Gynecologic oncology.

[5]  M. Piccart,et al.  A prospective study of the correlation between Ca 125 serum levels and surgically verified tumor burden in ovarian cancer (OV-CA) patients (PTS) , 1985 .

[6]  P. Wilkinson,et al.  Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker. , 1984, British Journal of Cancer.

[7]  J. Douillard,et al.  Radioimmunoassay of the CA 12 5 antigen in ovarian carcinomas: advantages compared with CA 19-9 and CEA. , 1984, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[8]  R. Bast,et al.  A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. , 1983, The New England journal of medicine.

[9]  R. Bast,et al.  Tissue Distribution of a Coelomic- Epithelium‐Related Antigen Recognized by the Monoclonal Antibody OC125 , 1983, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[10]  R. Bast,et al.  Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types. , 1983, American journal of clinical pathology.